Risk Assessment for Cancer-Associated VTE: Diversifying the Evidence Base

por Khorana, Alok A.
Publicado 2021

Evolving Treatment Options for Cancer-Related Venous Thromboembolism

por Attia, Doaa, Khorana, Alok A.
Publicado 2020

Preface to the Proceedings of the 10(th) International Conference on Thrombosis and Hemostasis Issues in Cancer, 2020

por Falanga, Anna, Brenner, Benjamin, Khorana, Alok A.
Publicado 2020

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

por Gervaso, Lorenzo, Dave, Heloni, Khorana, Alok A.
Publicado 2021

Thrombotic Complications Associated with Immune Checkpoint Inhibitors

por Wang, Tzu-Fei, Khorana, Alok A., Carrier, Marc
Publicado 2021

Abstract 24. Melanoma: How Much Does Time To Treatment Matter?

por Conic, Ruzica Z., Cabrera, Claudia, Khorana, Alok, Gastman, Brian
Publicado 2017

Predicting outcomes in patients with cancer and atrial fibrillation

por Gutierrez, Alejandra, Patell, Rushad, Rybicki, Lisa, Khorana, Alok A.
Publicado 2019

Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment—A report from ICTHIC 2021

por Falanga, Anna, Brenner, Benjamin, Khorana, Alok A., Francis, Charles W.
Publicado 2022

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States

por Khorana, Alok A, Dalal, Mehul R, Lin, Jay, Connolly, Gregory C
Publicado 2013

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban

por Bauersachs, Rupert, Khorana, Alok A., Lee, Agnes Y. Y., Soff, Gerald
Publicado 2020

Guidance for the prevention and treatment of cancer-associated venous thromboembolism

por Khorana, Alok A., Carrier, Marc, Garcia, David A., Lee, Agnes Y. Y.
Publicado 2016

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer

por Chaturvedi, Shruti, Sidana, Surbhi, Elson, Paul, Khorana, Alok A., McCrae, Keith R.
Publicado 2014

RNA expression and risk of venous thromboembolism in lung cancer

por Sussman, Tamara A., Abazeed, Mohamed E., McCrae, Keith R., Khorana, Alok A.
Publicado 2019

Impact of COVID-19 pandemic on treatment of colorectal cancer patients

por Elamin, Doua, Ozgur, Ilker, Steele, Scott R., Khorana, Alok A., Jia, Xue, Gorgun, Emre
Publicado 2023

Prevention of venous thromboembolism in ambulatory patients with cancer

por Khorana, Alok A, Cohen, Alexander T, Carrier, Marc, Meyer, Guy, Pabinger, Ingrid, Kavan, Petr, Wells, Philip S
Publicado 2020

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

por Sussman, Tamara A, Li, Hong, Hobbs, Brian, Funchain, Pauline, McCrae, Keith R, Khorana, Alok A
Publicado 2021

Comparison of characteristics and outcomes of young‐onset versus average onset pancreatico‐biliary adenocarcinoma

por Jayakrishnan, Thejus, Nair, Kanika G., Kamath, Suneel D., Wei, Wei, Estfan, Bassam N., Krishnamurthi, Smitha S., Khorana, Alok A.
Publicado 2023

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

por Lee, Agnes YY, Bauersachs, Rupert, Janas, Mette S, Jarner, Mikala F, Kamphuisen, Pieter W, Meyer, Guy, Khorana, Alok A
Publicado 2013

Racial disparities negatively impact outcomes in early‐onset colorectal cancer independent of socioeconomic status

por Kamath, Suneel D., Torrejon, Nataly, Wei, Wei, Tullio, Katherine, Nair, Kanika G., Liska, David, Krishnamurthi, Smitha S., Khorana, Alok A.
Publicado 2021

Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

por Khorana, Alok A, Palaia, Jennell, Rosenblatt, Lisa, Pisupati, Radhika, Huang, Ning, Nguyen, Chi, Barron, John, Gallagher, Kerrin, Bond, T Christopher
Publicado 2023